Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 24
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
20,037
-1.74%
|
$11,901,978
$594.91 P/Share
|
|
Aug 24
2020
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,037
+8.77%
|
$1,776,549
$177.82 P/Share
|
|
Aug 21
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
1,000
-15.05%
|
$617,000
$617.18 P/Share
|
|
Aug 21
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
19,963
-4.58%
|
$12,097,578
$606.57 P/Share
|
|
Aug 21
2020
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,963
+4.27%
|
$1,165,671
$117.47 P/Share
|
|
Aug 20
2020
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Payment of exercise price or tax liability
|
Direct |
47,891
-50.41%
|
$29,405,074
$614.09 P/Share
|
|
Aug 20
2020
|
Daniel P Van Plew EVP & General Mgr Industrial O |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+44.12%
|
$13,425,000
$179.13 P/Share
|
|
Aug 20
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
21,000
-1.89%
|
$12,957,000
$617.45 P/Share
|
|
Aug 20
2020
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.04%
|
$570,000
$57.11 P/Share
|
|
Aug 20
2020
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-6.68%
|
$612,000
$612.15 P/Share
|
|
Aug 20
2020
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+6.26%
|
$342,000
$342.93 P/Share
|
|
Aug 11
2020
|
P Roy Vagelos Director |
SELL
Open market or private sale
|
Indirect |
33,460
-3.79%
|
$20,109,460
$601.32 P/Share
|
|
Aug 04
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
696
-2.82%
|
$455,184
$654.46 P/Share
|
|
Aug 03
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.02%
|
$64,000
$640.5 P/Share
|
|
Jul 27
2020
|
George Yancopoulos President and Chief Scientific |
SELL
Bona fide gift
|
Indirect |
57,465
-100.0%
|
-
|
|
Jul 21
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
391
-0.78%
|
$254,932
$652.75 P/Share
|
|
Jul 21
2020
|
Christopher R. Fenimore VP Controller |
SELL
Open market or private sale
|
Direct |
3,709
-1.46%
|
$2,384,887
$643.32 P/Share
|
|
Jul 20
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,413
-12.87%
|
$4,855,515
$655.57 P/Share
|
|
Jul 20
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+12.86%
|
$4,054,500
$477.66 P/Share
|
|
Jul 20
2020
|
Christopher R. Fenimore VP Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
12,224
+18.92%
|
$1,405,760
$115.58 P/Share
|
|
Jul 20
2020
|
Christopher R. Fenimore VP Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
6,291
-24.89%
|
$4,120,605
$655.57 P/Share
|
|
Jul 14
2020
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
6,309
-0.61%
|
$3,949,434
$626.69 P/Share
|
|
Jul 14
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
579
-2.36%
|
$370,560
$640.5 P/Share
|
|
Jul 13
2020
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
6,691
-12.18%
|
$4,168,493
$623.98 P/Share
|
|
Jul 13
2020
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+19.13%
|
$390,000
$30.63 P/Share
|
|
Jul 13
2020
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
8,000
-1.24%
|
$5,016,000
$627.1 P/Share
|
|
Jul 09
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,421
-8.98%
|
$1,554,282
$642.46 P/Share
|
|
Jul 09
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+10.01%
|
$1,197,000
$399.66 P/Share
|
|
Jul 08
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
1,160
-0.39%
|
$744,720
$642.09 P/Share
|
|
Jul 07
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,340
-17.44%
|
$7,257,600
$640.88 P/Share
|
|
Jul 07
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+15.59%
|
$5,962,500
$477.66 P/Share
|
|
Jul 07
2020
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
1,706
-72.63%
|
$1,108,900
$650.0 P/Share
|
|
Jul 07
2020
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,706
+42.07%
|
$667,046
$391.92 P/Share
|
|
Jul 07
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Indirect |
3,000
-36.24%
|
$1,950,000
$650.35 P/Share
|
|
Jul 07
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
7,500
-6.1%
|
$4,875,000
$650.0 P/Share
|
|
Jul 07
2020
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+5.75%
|
$247,500
$33.42 P/Share
|
|
Jul 06
2020
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
341
-0.24%
|
-
|
|
Jul 01
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.02%
|
$61,200
$612.44 P/Share
|
|
Jul 01
2020
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
3,613
-13.92%
|
$2,207,543
$611.03 P/Share
|
|
Jul 01
2020
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,613
+45.91%
|
$1,492,169
$413.33 P/Share
|
|
Jun 29
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
400
-0.28%
|
$244,800
$612.6 P/Share
|
|
Jun 29
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Indirect |
3,000
-15.3%
|
$1,824,000
$608.51 P/Share
|
|
Jun 23
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
512
-0.26%
|
$322,560
$630.67 P/Share
|
|
Jun 22
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,388
-25.21%
|
$5,250,888
$626.19 P/Share
|
|
Jun 22
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,900
+21.1%
|
$4,939,500
$555.67 P/Share
|
|
Jun 19
2020
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
2,559
-40.63%
|
$1,612,170
$630.69 P/Share
|
|
Jun 19
2020
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,559
+44.42%
|
$1,000,569
$391.92 P/Share
|
|
Jun 16
2020
|
Christopher R. Fenimore VP Controller |
SELL
Open market or private sale
|
Direct |
3,556
-1.38%
|
$2,090,928
$588.96 P/Share
|
|
Jun 15
2020
|
Christopher R. Fenimore VP Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
9,406
+18.3%
|
$385,646
$41.33 P/Share
|
|
Jun 15
2020
|
Christopher R. Fenimore VP Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
3,670
-18.06%
|
$2,154,290
$587.9 P/Share
|